The CommSIG contributed by developing the key messages and design of these first ISoP infographics, as well as the ISoP strapline ' I Committed to safer medicines use worldwide' i for supporting ISoP outreach to medicines stakeholders. There are also cross-memberships and collaborations with the ISoP Special Interest Groups on Women's Medicines [[6]], Herbal and Traditional Medicines [[7]], Medication Errors [[8]], Vaccines [[9]], Risk Minimisation Methods for Asian Countries [[10]], and Patient Engagement [[11]], and with various regional ISoP Chapters. 3 Statement E. communication, medicines and patient safety (report of the Workshop on Drug Risk Communication held in Erice, 3-8 July 2009, organised by the International School of Pharmacology at the Ettore Majorana Foundation and Centre for Scientific Culture in Erice, Italy, in collaboration with the International Society of Pharmacovigilance (ISoP), the SK Foundation and the Uppsala Monitoring Centre (UMC)). Recognising the importance of communication, the International Society of Pharmacovigilance (ISoP) launched a Special Interest Group on Medicinal Product Risk Communication (CommSIG) in 2014 during the 14th Annual Meeting of ISoP in Tianjin, China, with a mandate to: Establish medicinal product risk communication as a discipline within pharmacovigilance, including integration of communication in all pharmacovigilance processes; Provide for multidisciplinary and global exchange, learning and development of communication practice; Promote research for planning and evaluating communication interventions [[1]]. [Extracted from the article]